Yubiologics Confirms Final Price for Rights Offering at 12,900 KRW per Share
[Asia Economy Reporter Lee Junhyung] UbioLogics announced on the 15th that it has finalized the issuance price of its paid-in capital increase, issuing 4,095,570 common shares at 12,900 KRW per share. The par value per share is 500 KRW, and the total issuance amount is approximately 52.8 billion KRW.
Hot Picks Today
Given Grants, Then Says "No Launch" ... Innovative Korean Technology Ultimately Forced Overseas
- "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- Singer Kim Minjong Responds to MC Mong's Gambling Allegations: "Clearly False... Legal Action to Follow"
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Cheaper Than Candy, Yet Impossible to Find... Fears of a 'Pediatric Medical Crisis' as Pharmaceutical Companies Halt Production [Why&Next]](https://cwcontent.asiae.co.kr/asiaresize/307/2026051910065268365_1779152813.jpg)
